Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Fatal and Serious Anaphylaxis Following Peginesatide Administration

Charles L. Bennett, MD, PhD, MPP, Sony Jacob, MD, Iain C Macdougall, MD, Tom Moore, Peter Georgantopoulos, MPH, MA, Judy Nichols, Paul Yarnold, PhD, Oliver Sartor, MD, Dennis W. Raisch, PhD, MS, RPh, Ashraf Mikhail, MD, LeAnn Norris, PharmD, Samuel Kessler, BA, Jametta Magwood, BA, David Goldsmith, MB, ChB

Blood (2013) 122 (21): 5612.

https://doi.org/10.1182/blood.V122.21.5612.5612

Published: 2013

Journal Articles

First Estimates of Incidence of Progressive Multifocal Leukoencephalopathy Developing Among 10,459 Non-HIV Lymphoma VA Patients Who Receive Rituximab: Results From the Veterans Administration Database (1999–2012).

Gowtham Rao, MD, PhD, Peter Georgantopoulos, MPH, AM, Kathlyn Sue Haddock, RN, PhD, Kenneth R. Carson, MD, LeAnn Norris, PharmD, Oliver Sartor, MD, Charles Bennett, MD, PhD, MPP

Blood (2012) 120 (21): 2752.

https://doi.org/10.1182/blood.V120.21.2752.2752

Published: 2012

Journal Articles

Location, Location, Location: Reassessing Erythropoiesis Stimulating Agents (ESAs) in the United States (US), Canada, and Europe (2007−2011)

Leann Norris, PharmD, Donald Mattison, M.D., CAPT, USPHS, Zaina Parvez Qureshi, PhD, MPH, Charles Bennett, MD, PhD, MPP

Blood (2011) 118 (21): 4753.

https://doi.org/10.1182/blood.V118.21.4753.4753

Published: 2011

Journal Articles

Translating Research Into Policy: A Review of Pharmacovigilance Efforts From the Southern Network On Adverse Reactions (SONAR) Group

Charles Bennett, MD, PhD, MPP, Leann Norris, PharmD, Zaina Parvez Qureshi, PhD, MPH, April Miller, PharmD, Brandon Bookstaver, PharmD, BCPS (AQ-ID), AAHIVE, Donald Mattison, M.D., CAPT, USPHS

Blood (2011) 118 (21): 4756.

https://doi.org/10.1182/blood.V118.21.4756.4756

Published: 2011

Journal Articles

Serious Adverse Drug Reactions (sADRS) Associated with Hematopoietic Growth Factors: A Systematic Review From the Southern Network on Adverse Reactions (SONAR) Program

LeAnn Norris, PharmD, Zaina Qureshi, PhD, MPH, Sara Barnato, Stephen Lai, MD, PhD, Charles Bennett, MD, PhD, MPP

Blood (2010) 116 (21): 2555.

https://doi.org/10.1182/blood.V116.21.2555.2555

Published: 2010

NARROW

Fatal and Serious Anaphylaxis Following Peginesatide Administration

First Estimates of Incidence of Progressive Multifocal Leukoencephalopathy Developing Among 10,459 Non-HIV Lymphoma VA Patients Who Receive Rituximab: Results From the Veterans Administration Database (1999–2012).

Location, Location, Location: Reassessing Erythropoiesis Stimulating Agents (ESAs) in the United States (US), Canada, and Europe (2007−2011)

Translating Research Into Policy: A Review of Pharmacovigilance Efforts From the Southern Network On Adverse Reactions (SONAR) Group

Serious Adverse Drug Reactions (sADRS) Associated with Hematopoietic Growth Factors: A Systematic Review From the Southern Network on Adverse Reactions (SONAR) Program

Email alerts

ASH Publications

American Society of Hematology

Fatal and Serious Anaphylaxis Following Peginesatide Administration

First Estimates of Incidence of Progressive Multifocal Leukoencephalopathy Developing Among 10,459 Non-HIV Lymphoma VA Patients Who Receive Rituximab: Results From the Veterans Administration Database (1999–2012).

Location, Location, Location: Reassessing Erythropoiesis Stimulating Agents (ESAs) in the United States (US), Canada, and Europe (2007−2011)

Translating Research Into Policy: A Review of Pharmacovigilance Efforts From the Southern Network On Adverse Reactions (SONAR) Group

Serious Adverse Drug Reactions (sADRS) Associated with Hematopoietic Growth Factors: A Systematic Review From the Southern Network on Adverse Reactions (SONAR) Program

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only